Clinical Trial Update: Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes [NA]

View source ↗

Summary

This document reports on an ongoing clinical trial evaluating the effect of sitagliptin on gut microbiota in patients newly diagnosed with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN